PharmGen Ai
PharmGenAi provides a drug discovery platform that uses advanced computational modeling, AI, and scientific evidence to identify and develop bioactive compounds. Its Q-REVEL+ methodology combines quantum computational modeling and Deep Learning to speed up discovery and achieve atomic precision. The platform enables rational design and in silico validation of next-generation drug candidates across oncology, neurodegenerative diseases, and aesthetics. Core technologies include deep learning, AI, quantum computational modeling, and in silico validation, supporting optimized ADMET profiles and patentability. The approach targets startups and biotechs in cosmetics and therapeutics.
PharmGen Ai
PharmGenAi provides a drug discovery platform that uses advanced computational modeling, AI, and scientific evidence to identify and develop bioactive compounds. Its Q-REVEL+ methodology combines quantum computational modeling and Deep Learning to speed up discovery and achieve atomic precision. The platform enables rational design and in silico validation of next-generation drug candidates across oncology, neurodegenerative diseases, and aesthetics. Core technologies include deep learning, AI, quantum computational modeling, and in silico validation, supporting optimized ADMET profiles and patentability. The approach targets startups and biotechs in cosmetics and therapeutics.